Swipe om te navigeren naar een ander artikel
Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by progressive sinopulmonary disease, with symptoms starting soon after birth. The aim of this study is to critically review, analyse, and synthesise the literature in order to understand the experiences of patients with primary ciliary dyskinesia (PCD) and the impact on health-related quality of life.
MEDLINE, EBSCO, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO and EMBASE were searched according to the inclusion criteria. A qualitative analysis of 14 studies was conducted.
Fourteen studies were included in the review, five with qualitative methodologies. Studies originated from the UK, USA, Italy, Denmark and Belgium, one study included a survey distributed internationally. Significant relationships were found between age and worsening of respiratory symptoms, physical, and mental domains of health-related quality of life, with a greater decline compared with reference populations. Variations between the UK and Italy were found for health-related quality of life and its correlation with time since diagnosis. PCD was found to have a physical impact in all age groups: patients found it difficult to keep up with others, and found energy levels were easily depleted compared to family or peers. In terms of social impact, symptoms lead to embarrassment and a sense of isolation, with patients concealing symptoms and/or their diagnosis. In turn, isolation was also linked with the lack of public and medical knowledge. In relation to emotional impact, anxiety was reported in a number of qualitative studies; patients were anxious about getting sick or when thinking about their future health. The burden of treatment and factors influencing adherence were also discussed in depth.
Health-related quality of life decreases with age in patients with PCD. For all age groups, PCD was found to greatly impact physical, emotional, social functioning, and treatment burden. More research is needed on the psychosocial impact of the illness, disease burden and its effect on quality of life.
Noone, P. G., Leigh, M. W., Sannuti, A., Minnix, S. L., Carson, J. L., Hazucha, M., et al. (2004). Primary ciliary dyskinesia: Diagnostic and phenotypic features. American Journal of Respiratory Critical Care & Medicine, 169, 459–467 CrossRef
Dell, S., Leigh, M., Ferkol, T., Knowles, M., Alpern, A., Behan, L., et al. (2014). Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD. European Respiratory Journal, 44, 1248
Pifferi, M., Bush, A., Di Cicco, M., Pradal, U., Ragazzo, V., Macchia, P., et al. (2010). Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology, 35(4), 787–794. CrossRef
Taelman, A., Havermans, T., & Boon, M. (2014). Adherence to treatment in children with primary ciliary dyskinesia (PCD): Identifying attitudes and perceived barriers to prescribed treatment. Pediatric Pulmonology, 49, S49–S50. CrossRef
Taelman, A., Boon, M., Dupont, L., & Havermans, T. (2014). Living with primary ciliary dyskinesia. European Respiratory Journal, 44, P3676.
Shapiro, A. J., Zariwala, M. A., Ferkol, T., Davis, S. D., Sagel, S. D., Dell, S. D., et al. (2015). Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatric Pulmonology, 51, 115–132. CrossRefPubMedPubMedCentral
Saunders, B. (2014). Stigma, deviance and morality in young adults’ accounts of inflammatory bowel disease. Sociology of Health & Illness, 36(7), 1020–1036. CrossRef
Aydemir, N., Özkara Ç, Ünsal, P., & Canbeyli, R. (2011). A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine. Seizure: The Journal of the British Epilepsy Association, 20(9), 679–685. CrossRef
Duff, A. J. A., & Latchford, G. J. (2010). Motivational interviewing for adherence problems in cystic fibrosis. Pediatric Pulmonology, 45(3), 211–220. PubMed
Festinger, L. (1962). A theory of cognitive dissonance. Stanford: Stanford university press.
U.S. Department of Health and Human Services; Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Dec 2009 [updated Dec 2009; cited 2015 September 24].
Apolone, G., De Carli, G., Brunetti, M., & Garattini, S. (2001). Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval. Pharmacoeconomics, 19(2), 187–195. CrossRefPubMed
European Medicines Agency: Committee for Medicinal Products for Human Use (CMHP). Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL) measures in the evaluation of medicinal products. 2005 [cited 2015 August 4].
Behan, L. L. M., Dell, S., Galvin, A. D., Quittner, A. L., & Lucas, J. S. (2017). Validation of a health-related quality of life instrument for primary ciliary dyskinesia (QOL-PCD). Thorax.
- The patient’s experience of primary ciliary dyskinesia: a systematic review
Jane S. Lucas
Audrey Dunn Galvin
- Springer International Publishing